Omalizumab for isolated idiopathic angioedema: A case report and short literature review

JDDG: Journal der Deutschen Dermatologischen GesellschaftEarly View CLINICAL LETTER Omalizumab for isolated idiopathic angioedema: A case report and short literature review Enrico Zelin, Corresponding Author Enrico Zelin [email protected] orcid.org/0000-0001-9276-3627 Dermatology Clinic, Maggiore Hospital, University of Trieste, Trieste, Italy Correspondence Enrico Zelin, MD, Dermatology Clinic, Maggiore Hospital, Piazza dell'Ospitale 1, 34129, Trieste, Italy. Email: [email protected]Search for more papers by this authorVanessa Mazzoletti, Vanessa Mazzoletti Department of Health Sciences, University of Eastern Piedmont, Novara, ItalySearch for more papers by this authorGiulia Bazzacco, Giulia Bazzacco Dermatology Clinic, Maggiore Hospital, University of Trieste, Trieste, ItalySearch for more papers by this authorLudovica Toffoli, Ludovica Toffoli Dermatology Clinic, Maggiore Hospital, University of Trieste, Trieste, ItalySearch for more papers by this authorClaudio Conforti, Claudio Conforti Dermatology Clinic, Maggiore Hospital, University of Trieste, Trieste, ItalySearch for more papers by this authorNicola Di Meo, Nicola Di Meo Dermatology Clinic, Maggiore Hospital, University of Trieste, Trieste, ItalySearch for more papers by this authorIris Zalaudek, Iris Zalaudek Dermatology Clinic, Maggiore Hospital, University of Trieste, Trieste, ItalySearch for more papers by this author Enrico Zelin, Corresponding Author Enrico Zelin [email protected] orcid.org/0000-0001-9276-3627 Dermatology Clinic, Maggiore Hospital, University of Trieste, Trieste, Italy Correspondence Enrico Zelin, MD, Dermatology Clinic, Maggiore Hospital, Piazza dell'Ospitale 1, 34129, Trieste, Italy. Email: [email protected]Search for more papers by this authorVanessa Mazzoletti, Vanessa Mazzoletti Department of Health Sciences, University of Eastern Piedmont, Novara, ItalySearch for more papers by this authorGiulia Bazzacco, Giulia Bazzacco Dermatology Clinic, Maggiore Hospital, University of Trieste, Trieste, ItalySearch for more papers by this authorLudovica Toffoli, Ludovica Toffoli Dermatology Clinic, Maggiore Hospital, University of Trieste, Trieste, ItalySearch for more papers by this authorClaudio Conforti, Claudio Conforti Dermatology Clinic, Maggiore Hospital, University of Trieste, Trieste, ItalySearch for more papers by this authorNicola Di Meo, Nicola Di Meo Dermatology Clinic, Maggiore Hospital, University of Trieste, Trieste, ItalySearch for more papers by this authorIris Zalaudek, Iris Zalaudek Dermatology Clinic, Maggiore Hospital, University of Trieste, Trieste, ItalySearch for more papers by this author First published: 09 April 2024 https://doi.org/10.1111/ddg.15359Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES 1Belbézier A, Bocquet A, Bouillet L. Idiopathic Angioedema: Current Challenges. J Asthma Allergy. 2020; 13: 137-144. 10.2147/JAA.S205709 CASPubMedGoogle Scholar 2Brunetta E, Shiffer D, Folci M, et al. Omalizumab for idiopathic nonhistaminergic angioedema: evidence for efficacy in 2 patients. Case Reports Immunol. 2018; 2018: 1-3. 10.1155/2018/8067610 Google Scholar 3Weller K, Groffik A, Magerl M, et al. Development and construct validation of the angioedema quality of life questionnaire. Allergy. 2012; 67(10): 1289-1298. 10.1111/all.12007 CASPubMedWeb of Science®Google Scholar 4Goswamy V, Lee K, McKernan E, et al. A phase IV, Randomized, double-blind, placebo-controlled exploratory study of omalizumab for treatment of idiopathic angioedema in patients who remain symptomatic despite current therapy. J Allergy Clin Immunol. 2022; 149(2):AB166. 10.1016/j.jaci.2021.12.552 Google Scholar 5Bucher MC, Petkovic T, Helbling A, Steiner UC. Idiopathic non-histaminergic acquired angioedema: a case series and discussion of published clinical trials. Clin Transl Allergy. 2017; 7(1): 27. 10.1186/s13601-017-0164-9 PubMedWeb of Science®Google Scholar 6Muñoz JP, Casado AF, Taboada AC, et al. Successful treatment of refractory idiopathic angio-oedema with omalizumab: review of the literature and function of IgE in angio-oedema. Clin Exp Dermatol. 2016; 41(4): 399-402. 10.1111/ced.12779 PubMedGoogle Scholar 7Faisant C, Du Thanh A, Mansard C, et al. Idiopathic Non-histaminergic Angioedema: Successful Treatment with Omalizumab in Five Patients. J Clin Immunol. 2017; 37(1): 80-84. 10.1007/s10875-016-0345-7 PubMedGoogle Scholar 8Kutlu A, Karabacak E, Aydin E, et al. Efficacy of omalizumab in a patient with angioedema clinically resembling a hereditary angioedema. Ann Dermatol. 2016; 28(3): 381-382. 10.5021/ad.2016.28.3.381 PubMedGoogle Scholar 9Azofra J, Díaz C, Antépara I, et al. Positive response to omalizumab in patients with acquired idiopathic nonhistaminergic angioedema. Ann Allergy, Asthma Immunol. 2015; 114(5): 418-419. e1. 10.1016/j.anai.2015.02.007 CASPubMedWeb of Science®Google Scholar 10Ozturk AB, Kocaturk E. Omalizumab in recurring larynx angioedema: a case report. Asia Pac Allergy. 2014; 4(2): 129. 10.5415/apallergy.2014.4.2.129 PubMedGoogle Scholar 11Von Websky A, Reich K, Steinkraus V, Breuer K. Complete remission of severe chronic recurrent angioedema of unknown cause with omalizumab. J Dtsch Dermatol Ges. 2013 Jul; 11(7): 677-678. 10.1111/ddg.12075 PubMedGoogle Scholar 12Suna B, Asli G, Ferhan O, et al. Successful treatment of chronic idiopathic angioedema with omalizumab. Allergy. 2010; 65(Suppl 92[Congress abstract]): 459. PubMedGoogle Scholar 13Sands MF, Blume JW, Schwartz SA. Successful treatment of 3 patients with recurrent idiopathic angioedema with omalizumab. J Allergy Clin Immunol. 2007; 120(4): 979-981. 10.1016/j.jaci.2007.07.041 CASPubMedGoogle Scholar Early ViewOnline Version of Record before inclusion in an issue ReferencesRelatedInformation